Table 3 Two-way ANOVA analysis of individual bisphenol A dose (BPA0.5 and BPA50) on the plasma metabolome

From: Developmental low-dose bisphenol A exposure leads to extensive transcriptome female masculinization and male feminization later in life

BPA0.5

2-way ANOVA

 

Direction

Post-hoc Tukey

NMR name

BPA

sex*BPA

p-value

Male

Female

p-value

Change

Main

 

ABA1

0.0273

Up

 

0.0347

mBPA0.5 vs all

ApoB

 

L6PN

0.00629

  

0.146

 

Main V/L/H

 

HDPL

0.0122

  

0.176

 

Sub VLDL

 

V5CH

0.0482

Up

Down

0.00525

mBPA0.5 vs fBPA0.5

  

V5PL

0.0135

Up

Down

0.0233

mBPA0.5 vs fBPA0.5

Sub LDL

 

L6TG

0.0427

Up

Down

0.0003

mBPA0.5 vs fBPA0.5

  

L6CH

0.00124

Up

 

0.0307

mCont vs mBPA0.5

  

L6FC

0.00248

  

0.0516

 
  

L6PL

0.00219

Up

 

0.0413

mCont vs mBPA0.5

  

L6AB

0.00630

  

0.147

 

Sub HDL

 

H3CH

0.0252

  

0.322

 
  

H3PL

0.00056

Down

 

0.0269

mCont vs mBPA0.5

  

H3A1

0.0240

  

0.124

 

Small Metab

Ile

 

0.00632

Up

 

0.0031

mBPA0.5 vs fCont

  

Leu

0.0449

Up

Down

0.0464

fCont vs mCont

  

Formate

0.0403

Down

Up

0.0325

mCont vs fCont

BPA50

2-way ANOVA

 

Direction

Post-hoc Tukey

NMR name

BPA

sex*BPA

p-value

Male

Female

p-value

Change

ApoB

 

L2PN

0.0123

  

0.173

 

Sub LDL

 

L2CH

0.0138

Up

Down

0.00016

fCont vs mCont

  

L2FC

0.00942

Up

Down

0.00016

fCont vs mCont

  

L2PL

0.00248

Up

Down

0.00016

fCont vs mCont

  

L2AB

0.0123

  

0.172

 

Small Metab

 

Gly

0.0389

  

0.197

 
 

Phe

 

0.0200

Up

 

0.0484

mBPA0.5 vs fCont

  1. The table shows the lipoprotein identity and significant changes caused by individual developmental BPA-dose exposure. Post-hoc analysis indicates the Direction (up or down) of change, and Change indicates the statistically significant comparison
  2. NMR (see legend of Supplementary Fig. 3): ABA1 (Apo-B1/Apo-A1), L6PN (high-density LDL, particle number), HDPL (HDL, phospholipids), V5CH/PL (high-density VLDL, cholesterol/phospholipid), L6TG/CH/FC/PL/AB (high-density LDL, triacylglycerol/cholesterol/free cholesterol/phospholipid/Apo-B1), H3CH/PL/A1 (HDL, cholesterol/phospholipid/Apo-A1), L2PN/CH/FC/PL/AB (low-density LDL, particle number/cholesterol/free cholesterol/phospholipid/Apo-B1), Ile (isoleucine), Leu (leucine), Gly (glycine) and Phe (phenylalanine). f (female), m (male), Cont (controls). Exposure groups: BPA0.5 (0.5 μg BPA/kg BW/day) and BPA50 (50 μg BPA/kg BW/day). Number of animals/group: control females n = 11, BPA0.5 exposed females n = 8, BPA50 exposed females n = 7, control males n = 12, BPA0.5 exposed males n = 8, BPA50 exposed males n = 8. Two-way ANOVA, followed by the post-hoc Tukey test.